Provided by Tiger Fintech (Singapore) Pte. Ltd.

Packaging Corp of America

183.42
+3.421.90%
Pre-market: 181.92-1.5000-0.82%09:03 EDT
Volume:884.32K
Turnover:162.01M
Market Cap:16.38B
PE:19.19
High:184.53
Open:181.50
Low:180.61
Close:180.00
Loading ...
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2020

Major Issues Report

8-K - Current report
Sep 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 09, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
Jun 26, 2020

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
Jun 25, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
May 11, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
May 11, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
May 06, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, item 5.02